Mónica Marta

4.2k total citations · 1 hit paper
66 papers, 1.9k citations indexed

About

Mónica Marta is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Mónica Marta has authored 66 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 20 papers in Immunology and 15 papers in Oncology. Recurrent topics in Mónica Marta's work include Multiple Sclerosis Research Studies (28 papers), Polyomavirus and related diseases (10 papers) and Immunotherapy and Immune Responses (10 papers). Mónica Marta is often cited by papers focused on Multiple Sclerosis Research Studies (28 papers), Polyomavirus and related diseases (10 papers) and Immunotherapy and Immune Responses (10 papers). Mónica Marta collaborates with scholars based in United Kingdom, Sweden and Portugal. Mónica Marta's co-authors include Gavin Giovannoni, Klaus Schmierer, David Baker, Gareth Pryce, Benjamin Turner, Sharmilee Gnanapavan, Anna Lobell, Curtis Offiah, Olle Kämpe and Åsa Andersson and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Neurology.

In The Last Decade

Mónica Marta

63 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

2015 275 citations Gavin Giovannoni, Benjamin Turner et al. Multiple Sclerosis and Related Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mónica Marta United Kingdom	20	1.0k	761	487	368	307	66	1.9k
John S. Tzartos Greece	15	788 0.8×	955 1.3×	311 0.6×	340 0.9×	323 1.1×	69	2.0k
Jonatan Salzer Sweden	21	1.6k 1.5×	537 0.7×	490 1.0×	638 1.7×	201 0.7×	49	2.1k
Martin Duddy United Kingdom	21	1.1k 1.0×	1.0k 1.3×	260 0.5×	489 1.3×	262 0.9×	40	2.2k
Martin Gunnarsson Sweden	18	1.4k 1.3×	291 0.4×	436 0.9×	652 1.8×	322 1.0×	47	2.1k
Yu-Min Huang Sweden	27	557 0.5×	1.2k 1.6×	334 0.7×	347 0.9×	517 1.7×	80	2.5k
Rafael Arroyo Spain	26	762 0.7×	611 0.8×	333 0.7×	224 0.6×	356 1.2×	76	1.7k
Marco Capobianco Italy	26	1.6k 1.5×	547 0.7×	591 1.2×	769 2.1×	276 0.9×	83	2.2k
Konstantin Balashov United States	21	891 0.9×	1.5k 1.9×	679 1.4×	196 0.5×	318 1.0×	40	2.3k
Jessica Frau Italy	25	1.1k 1.0×	353 0.5×	255 0.5×	354 1.0×	317 1.0×	111	1.8k
Mefkûre Eraksoy Türkiye	28	1.2k 1.1×	405 0.5×	254 0.5×	810 2.2×	498 1.6×	97	2.4k

Countries citing papers authored by Mónica Marta

Since Specialization

Citations

This map shows the geographic impact of Mónica Marta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica Marta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica Marta more than expected).

Fields of papers citing papers by Mónica Marta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mónica Marta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica Marta. The network helps show where Mónica Marta may publish in the future.

Co-authorship network of co-authors of Mónica Marta

This figure shows the co-authorship network connecting the top 25 collaborators of Mónica Marta. A scholar is included among the top collaborators of Mónica Marta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mónica Marta. Mónica Marta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pugliese, Vincenzo, et al.. (2025). Retrospective comparative analyses of liver transplantation for intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma versus hepatocellular carcinoma in Brazil. HPB. 27(5). 640–648.

Ammoscato, Francesca, Jonathan P. Bestwick, Michael Andrews, et al.. (2024). Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells. Clinical Immunology. 269. 110380–110380. 4 indexed citations

Granziera, Cristina, et al.. (2024). Emerging imaging markers in radiologically isolated syndrome: implications for earlier treatment initiation. Neurological Sciences. 45(7). 3061–3068. 2 indexed citations

Dubuisson, Nicolas, Mónica Marta, Sharmilee Gnanapavan, et al.. (2023). Anaesthetic management of people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 80. 105045–105045. 2 indexed citations

Marta, Mónica, et al.. (2022). Disease activity after cladribine immune reconstitution therapy: To repeat or to retreat? (P9-4.002). Neurology. 98(18_supplement). 2 indexed citations

Dobson, Ruth, Matthew Craner, Aleisha Miller, et al.. (2021). OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. BMJ Open. 11(11). e050176–e050176. 2 indexed citations

Reyes, Saúl, Mary Ramsay, Shamez Ladhani, et al.. (2020). Protecting people with multiple sclerosis through vaccination. Practical Neurology. 20(6). 435.1–445. 36 indexed citations

Baker, David, Gareth Pryce, Louisa K. James, Mónica Marta, & Klaus Schmierer. (2020). The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.. Multiple Sclerosis and Related Disorders. 44. 102279–102279. 91 indexed citations

Middleton, Rod, Arron Lacey, Owen Pearson, et al.. (2019). 030 Automating clinical audit in neurology. Journal of Neurology Neurosurgery & Psychiatry. 90(12). A18.1–A18. 1 indexed citations

10.

Horne, Rachel, Caroline Chung, Mónica Marta, et al.. (2019). Visibility and representation of women in multiple sclerosis research. Neurology. 92(15). 713–719. 8 indexed citations

11.

Gold, Julian, Mónica Marta, Ute‐Christiane Meier, et al.. (2018). A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. Multiple Sclerosis and Related Disorders. 24. 123–128. 26 indexed citations

12.

Álvarez-González, César, Joela Mathews, Sharmilee Gnanapavan, et al.. (2017). Treating multiple sclerosis with generic cladribine. Queen Mary Research Online (Queen Mary University of London). 1 indexed citations

13.

Marta, Mónica, David MacManus, Tarek Yousry, et al.. (2016). Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study results. Multiple Sclerosis Journal. 21. 2 indexed citations

14.

Pakpoor, Julia, Giulio Disanto, Daniel R. Altmann, et al.. (2015). Cancer Risk is Not Increased in People with Relapsing Multiple Sclerosis Taking Cladribine (P7.011). Neurology. 84(14_supplement). 1 indexed citations

15.

Gnanapavan, Sharmilee, Donna Grant, S. V. Morant, et al.. (2013). Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression. PLoS ONE. 8(8). e70019–e70019. 42 indexed citations

16.

Maghzi, Amir‐Hadi, Mónica Marta, Isabel Boscá, et al.. (2010). Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?. Pathophysiology. 18(1). 13–20. 16 indexed citations

17.

Silva, Ana, Clara Pereira, Andreia Bettencourt, et al.. (2007). The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population. Journal of the Neurological Sciences. 258(1-2). 69–74. 40 indexed citations

18.

Jagodic, Maja, Mónica Marta, Kristina Bečanović, et al.. (2005). Resolution of a 16.8-Mb Autoimmunity-Regulating Rat Chromosome 4 Region into Multiple Encephalomyelitis Quantitative Trait Loci and Evidence for Epistasis. The Journal of Immunology. 174(2). 918–924. 21 indexed citations

19.

Khademi, Mohsen, Zsolt Illés, Alexander W. Gielen, et al.. (2004). T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis. The Journal of Immunology. 172(11). 7169–7176. 193 indexed citations

20.

Silva, Berta Martins da, Theodora Thorlacius, Clara Pereira, et al.. (2003). A whole genome association study in multiple sclerosis patients from north Portugal. Journal of Neuroimmunology. 143(1-2). 116–119. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact